当前位置: 首页 > 详情页

Cancer-associated fibroblasts from NSCLC promote the radioresistance in lung cancer cell lines.

| 认领 | 导出 |

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Department of Radiation Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, China [2]Department of Pathology, The Second Affiliated Hospital of Soochow University, Suzhou, China [3]Department of Thoracic Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, China
出处:
ISSN:

摘要:
The purpose of present study was to investigate the radiosensitivity of lung cancer cells affected by human lung cancer-associated fibroblasts (CAFs) in transwell and direct co-culture in vitro. Human lung CAFs was obtained from fresh human lung adenocarcinoma tissue specimens by primary culture with tissue explants method, and was identified by immunofluorescence staining. The radiosensitivity of A549 and H1299 lung cancer cells in mono-culture, transwell and direct co-culture with human lung CAFs were investigated by clonogenic survival assay, respectively. Human lung CAFs were obtained successfully, and had specific immuno-staining with α-SMA, Vimentin, and FAP, and no cytokeratin-18 expression. The plating efficiency (PE) of A549 cells without receiving irradiation were 0.206±0.031, 0.210±0.007 (>0.05) and 0.352±0.023 (<0.05) in mono-culture, transwell and direct co-culture, respectively. The PE of H1299 cells were 0.200±0.039, 0.259±0.024 (>0.05) and 0.323±0.025 (<0.05) in mono-culture, transwell and direct co-culture, respectively. The clonogenic survival assay showed that the protection enhancement ratio of human lung CAFs in transwell and direct co-culture were 1.11 and 1.29 for A549 cells, and 1.15 and 1.25 for H1299 cells, respectively. The results suggested that human lung CAFs promote the radioresistance of lung cancer cells significantly. Its radioprotective effect may attribute to CAFs stimulating lung cancer cell proliferation.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2014]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验
最新[2023]版:
JCR分区:
出版当年[2013]版:
Q3 MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q4 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2013版] 出版当年五年平均 出版前一年[2012版] 出版后一年[2014版]

第一作者:
第一作者机构: [1]Department of Radiation Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, China
通讯作者:
通讯机构: [*1]Department of Radiation Oncology, The Second Affiliated Hospital of Soochow University, 1055 Sanxiang Road, Suzhou 215004, Jiangsu Province, P. R. China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院